Calendar

Oct
12
Tue
2021
Cancer Early Detection Seminar Series - Azra Raza, MD @ Venue coming soon!
Cancer Early Detection Seminar Series – Azra Raza, MD
Oct 12 @ 11:00 am – 12:00 pm Venue coming soon!
Cancer Early Detection Seminar Series - Azra Raza, MD @ Venue coming soon!

CEDSS: The First Cell: A new model for cancer research and treatment

Azra Raza, M.D.
Chan Soon-Shiong Professor of Medicine
Director, Myelodysplastic Syndrome Center
Columbia University Medical Center

 

Location: Zoom
Meeting URL: https://stanford.zoom.us/s/99340345860
Dial: US: +1 650 724 9799  or +1 833 302 1536 (Toll Free)
Meeting ID: 993 4034 5860
Passcode: 711508

RSVP Here

 

ABSTRACT

Cancer research continues to be predicated on a 1970’s model of research and treatment. Despite half a century of intense research, we are failing spectacularly to improve the outcome for patients with advanced disease. Those who are cured continue to be treated mostly with the older strategies (surgery-chemo-radiation). Our contention is that the real solution to the cancer problem is to diagnose cancer early, at the stage of The First Cell. The rapidly evolving technologies are doing much in this area but need to be expanded. We study a pre-leukemic condition called myelodysplastic syndrome (MDS) with the hope that we can detect the first leukemia cells as the disease transforms to acute myeloid leukemia (AML). Towards this end, we have collected blood and bone marrow samples on MDS and AML patients since 1984. Today, our Tissue Repository has more than 60,000 samples. We propose novel methods to identify surrogate markers that can identify the First Cell through studying the serial samples of patients who evolve from MDS to AML.

 

ABOUT

Dr. Raza is a Professor of Medicine and Director of the MDS Center at Columbia University in New York, NY.She started her research in Myelodisplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010.

Before moving to New York, Dr. Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachussetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, British Journal of Hematology, Leukemia, and Leukemia Research. Dr. Raza serves on numerous national and international panels as a reviewer, consultant and advisor and is the recipient of a number of awards.

 

Hosted by: Utkan Demirci, Ph.D.
Spon
sored by: The Canary Center & the Department of Radiology 
Stanford University – School of Medicine

Nov
17
Wed
2021
IBIIS & AIMI Seminar: Deep Learning for Histology Images Analysis @ Zoom: https://stanford.zoom.us/j/91788140120?pwd=K2NvMHZ2SUFVWjc1d2xJUndjTG9lQT09
IBIIS & AIMI Seminar: Deep Learning for Histology Images Analysis
Nov 17 @ 12:00 pm – 1:00 pm Zoom: https://stanford.zoom.us/j/91788140120?pwd=K2NvMHZ2SUFVWjc1d2xJUndjTG9lQT09

Saeed Hassanpour, PhD
Associate Professor of Biomedical Data Science
Associate Professor of Epidemiology
Associate Professor of Computer Science
Dartmouth Geisel School of Medicine

Deep Learning for Histology Images Analysis

Abstract:
With the recent expansions of whole-slide digital scanning, archiving, and high-throughput tissue banks, the field of digital pathology is primed to benefit significantly from deep learning technology. This talk will cover several applications of deep learning for characterizing histopathological patterns on high-resolution microscopy images for cancerous and precancerous lesions. Furthermore, the current challenges for building deep learning models for pathology image analysis will be discussed and new methodological advances to address these bottlenecks will be presented.

About:

Dr. Saeed Hassanpour is an Associate Professor in the Departments of Biomedical Data Science, Computer Science, and Epidemiology at Dartmouth College. His research is focused on machine learning and multimodal data analysis for precision health. Dr. Hassanpour has led multiple NIH-funded research projects, which resulted in novel machine learning and deep learning models for medical image analysis and clinical text mining to improve diagnosis, prognosis, and personalized therapies. Before joining Dartmouth, he worked as a Research Engineer at Microsoft. Dr. Hassanpour received his Ph.D. in Electrical Engineering with a minor in Biomedical Informatics from Stanford University and completed his postdoctoral training at Stanford Center for Artificial Intelligence in Medicine & Imaging.

Dec
15
Wed
2021
IBIIS & AIMI Seminar: Indrani Bhattacharya, PhD & Rogier van der Sluijs, PhD @ Zoom: https://stanford.zoom.us/j/95371438521?pwd=Y3BheHpUanpESnh6VUkycVhlUWtodz09
IBIIS & AIMI Seminar: Indrani Bhattacharya, PhD & Rogier van der Sluijs, PhD
Dec 15 @ 12:00 pm – 1:00 pm Zoom: https://stanford.zoom.us/j/95371438521?pwd=Y3BheHpUanpESnh6VUkycVhlUWtodz09

Indrani Bhattacharya, PhD
Postdoctoral Research Fellow
Department of Radiology
Stanford University

Title: Multimodal Data Fusion for Selective Identification of Aggressive and Indolent Prostate Cancer on Magnetic Resonance Imaging

Abstract: Automated methods for detecting prostate cancer and distinguishing indolent from aggressive disease on Magnetic Resonance Imaging (MRI) could assist in early diagnosis and treatment planning. Existing automated methods of prostate cancer detection mostly rely on ground truth labels with limited accuracy, ignore disease pathology characteristics observed on resected tissue, and cannot selectively identify aggressive (Gleason Pattern≥4) and indolent (Gleason Pattern=3) cancers when they co-exist in mixed lesions. This talk will cover multimodal and multi-scale fusion approaches to integrate radiology images, pathology images, and clinical domain knowledge about prostate cancer distribution to selectively identify and localize aggressive and indolent cancers on prostate MRI.

Rogier van der Sluijs, PhD
Postdoctoral Research Fellow
Department of Radiology
Stanford University

Title: Pretraining Neural Networks for Medical AI

Abstract: Transfer learning has quickly become standard practice for deep learning on medical images. Typically, practitioners repurpose existing neural networks and their corresponding weights to bootstrap model development. This talk will cover several methods to pretrain neural networks for medical tasks. The current challenges for pretraining neural networks in Radiology will be discussed and recent advancements that address these bottlenecks will be highlighted.

Jan
19
Wed
2022
IBIIS & AIMI Seminar: AI In Clinical Use – Lessons Learned @ Zoom: https://stanford.zoom.us/j/92632628279?pwd=S3RFdXdEUmEweTNKelhrcmVxQUExdz09
IBIIS & AIMI Seminar: AI In Clinical Use – Lessons Learned
Jan 19 @ 12:00 pm – 1:00 pm Zoom: https://stanford.zoom.us/j/92632628279?pwd=S3RFdXdEUmEweTNKelhrcmVxQUExdz09

Nina Kottler, MD, MS
Associate Chief Medical Officer, Clinical AI
VP Clinical Operations
Radiology Partners

Abstract:
We have a call to action in healthcare – we need to drive value.  Artificial intelligence (AI), if deployed correctly, can help accomplish this lofty mission.  In this discussion we will review the following lessons learned in deploying radiology AI at scale:  4 unexpected benefits of implementing AI emergent finding triage; the importance of investing in AI radiologist education; how “most” AI needs to be incorporated into the radiologist workflow; why a platform is required to deploy AI at scale and what a modern platform looks like; how to use AI to add value to your data; and, as Dr. Curt Langlotz famously said, why rads (practices) who use AI will replace those who don’t (a depiction of what the role of the radiologist might look like in a tech enabled future).

Bio:
Dr. Kottler has been a practicing radiologist specializing in emergency imaging for over 16 years.  Combining her clinical experience with a graduate degree in applied mathematics, she has been using technological innovation to drive value in radiology.  As the first radiologist to join Radiology Partners, Dr. Kottler has held multiple leadership positions within her practice and is currently the associate Chief Medical Officer for Clinical AI.  Externally Dr. Kottler serves on multiple committees for the ACR, RSNA, and SIIM.  Dr. Kottler is also passionate about promoting diversity and creating a culture of belonging.  As such she is a member of the AAWR, is a member of the diversity and inclusion committee at SIIM, serves on the steering committee for RAD=, and leads the education and development division of the Belonging Committee within Radiology Partners.

Feb
16
Wed
2022
IBIIS & AIMI Seminar: Imaging Analytics for Neuro-Oncology: Towards Computational Diagnostics @ ZOOM: https://stanford.zoom.us/j/98789338790?pwd=OXRORjhYUUdaRGJpUHJZdzZ5NGw5dz09
IBIIS & AIMI Seminar: Imaging Analytics for Neuro-Oncology: Towards Computational Diagnostics
Feb 16 @ 12:00 pm – 1:00 pm ZOOM: https://stanford.zoom.us/j/98789338790?pwd=OXRORjhYUUdaRGJpUHJZdzZ5NGw5dz09

Spyridon (Spyros) Bakas, PhD
Assistant Professor in the Department of Pathology,
Laboratory Medicine, and of Radiology
Center for Biomedical Image Computing and Analytics (CBICA)
Perelman School of Medicine
University of Pennsylvania

Title: Imaging Analytics for Neuro-Oncology:
Towards Computational Diagnostics

Abstract: Central nervous system (CNS) tumors come with vastly heterogeneous histologic, molecular, and radiographic landscapes, rendering their precise characterization challenging. The rapidly growing fields of biophysical modeling and radiomics have shown promise in better characterizing the molecular, spatial, and temporal heterogeneity of tumors. Integrative analysis of CNS tumors, including clinically acquired multi-parametric magnetic resonance imaging (mpMRI), assists in identifying macroscopic quantifiable tumor patterns of invasion and proliferation, potentially leading to improved (a) detection/segmentation of tumor subregions and (b) computer-aided diagnostic/prognostic/predictive modeling. This talk will touch upon example studies on this space, as well as an overview of the largest to-date real-world federated learning study to detect brain tumor boundaries.

Mar
16
Wed
2022
IBIIS & AIMI Seminar: Using AI for Longitudinal Tumor Response Monitoring and AI Guided Cancer Treatments: From Lab to Clinic @ ZOOM: https://stanford.zoom.us/j/99319571697?pwd=c2lhRkN4cXEzTzFzMUhKaTVJMHZLQT09
IBIIS & AIMI Seminar: Using AI for Longitudinal Tumor Response Monitoring and AI Guided Cancer Treatments: From Lab to Clinic
Mar 16 @ 12:00 pm – 1:00 pm ZOOM: https://stanford.zoom.us/j/99319571697?pwd=c2lhRkN4cXEzTzFzMUhKaTVJMHZLQT09

Harini Veeraraghavan, PhD
Associate Attending Computer Scientist
Department of Medical Physics
Memorial Sloan-Kettering Cancer Center

Using AI for Longitudinal Tumor Response Monitoring and AI Guided Cancer Treatments: From Lab to Clinic

Abstract:
Cancer patients are imaged with multiple imaging modalities as part of routine cancer care. However, the rich information available from the images are not fully exploited to better manage patient care through earlier intervention as well as more precise targeted treatments. In this talk, I will present some of the new AI methodologies we have been developing to track tumor response as well as from routinely acquired imaging applied to image-guided radiation treatments using CT/cone-beam CT as well as MRI-guided precision treatments. I will also present some demonstration studies of how AI based automated segmentation and tumor as well as healthy tissue change assessment can be used to early detect treatment toxicities to enable clinicians to better manage cancer care. Finally, I will show how these developed methods have been put to routine clinical care for automating radiotherapy treatment planning at MSK.

Apr
14
Thu
2022
IBIIS & AIMI Seminar: Imaging Analytics for Neuro-Oncology: Towards Computational Diagnostics @ Zoom: https://stanford.zoom.us/j/98789338790?pwd=OXRORjhYUUdaRGJpUHJZdzZ5NGw5dz09
IBIIS & AIMI Seminar: Imaging Analytics for Neuro-Oncology: Towards Computational Diagnostics
Apr 14 @ 11:00 am – 12:00 pm Zoom: https://stanford.zoom.us/j/98789338790?pwd=OXRORjhYUUdaRGJpUHJZdzZ5NGw5dz09

Spyridon (Spyros) Bakas, PhD
Assistant Professor in the Department of Pathology,
Laboratory Medicine, and of Radiology
Center for Biomedical Image Computing and Analytics (CBICA)
Perelman School of Medicine
University of Pennsylvania

Title: Imaging Analytics for Neuro-Oncology: Towards Computational Diagnostics

Central nervous system (CNS) tumors come with vastly heterogeneous histologic, molecular, and radiographic landscapes, rendering their precise characterization challenging. The rapidly growing fields of biophysical modeling and radiomics have shown promise in better characterizing the molecular, spatial, and temporal heterogeneity of tumors. Integrative analysis of CNS tumors, including clinically acquired multi-parametric magnetic resonance imaging (mpMRI), assists in identifying macroscopic quantifiable tumor patterns of invasion and proliferation, potentially leading to improved (a) detection/segmentation of tumor subregions and (b) computer-aided diagnostic/prognostic/predictive modeling. This talk will touch upon example studies on this space, as well as an overview of the largest to-date real-world federated learning study to detect brain tumor boundaries.

Apr
20
Wed
2022
IBIIS & AIMI Seminar: Automated Workflows for Neuro-Oncology Image Analysis @ Zoom: https://stanford.zoom.us/j/94439662481?pwd=N1BUc2FqWUt4QVlQMnNSS21rcEV4UT09
IBIIS & AIMI Seminar: Automated Workflows for Neuro-Oncology Image Analysis
Apr 20 @ 12:00 pm – 1:00 pm Zoom: https://stanford.zoom.us/j/94439662481?pwd=N1BUc2FqWUt4QVlQMnNSS21rcEV4UT09

Daniel Marcus, PhD
Professor of Radiology
Director of the Neuroinformatics Research Group
Director of the Neuroimaging Informatics and Analysis Center
Washington University

Abstract:
Developing and deploying computational tools for neuro-oncology applications includes a sequence of complex steps to identify appropriate images, assess image quality, annotate, process and other prepare and manipulate data for analysis. We have implemented services and tools on the open source XNAT informatics platform to automate much of this workflow to improve both its efficiency and effectiveness. Dr. Marcus will discuss this automated workflow and its implementation in a number of data sets and applications at Washington University.

May
18
Wed
2022
IBIIS & AIMI Seminar: Missing the (Bench)mark? @ Zoom: https://stanford.zoom.us/j/95872488712?pwd=dDhmT1JPdWtTSlBOQ1BENmtGOUxjUT09
IBIIS & AIMI Seminar: Missing the (Bench)mark?
May 18 @ 9:30 am – 10:30 am Zoom: https://stanford.zoom.us/j/95872488712?pwd=dDhmT1JPdWtTSlBOQ1BENmtGOUxjUT09

Lena Maier-Hein, PhD
Head of Department, Computer Assisted Medical Interventions
Managing Director, Data Science and Digital Oncology
Managing Director, National Center for Tumor Diseases
German Cancer Research Center

Title: Missing the (Bench)mark?

Abstract

Machine learning has begun to revolutionize almost all areas of health research. Success stories cover a wide variety of application fields ranging from radiology and gastroenterology all the way to mental health. Strikingly, however, solutions that perform favorably in research generally do not translate well to clinical practice, and little attention is being given to learning from failures. Focusing on biomedical image analysis as a key area of health-related machine learning, this talk will present pitfalls, caveats and recommendations related to machine learning-based biomedical image analysis. As a particular highlight, it will cover yet unpublished work on two key research questions related to biomedical image analysis competitions: 1) How can we best select performance metrics according to the characteristics of the driving biomedical question? And 2) Why is the winner the best? The results have been compiled based on the input of hundreds of image analysis researchers worldwide.

Jun
16
Thu
2022
IBIIS & AIMI Seminar: Medical AI Safety - A Clinical Perspective @ Zoom: https://stanford.zoom.us/j/93524639045?pwd=NUV1MFE2clBCYVp3K0FJNlJFTGswdz09
IBIIS & AIMI Seminar: Medical AI Safety – A Clinical Perspective
Jun 16 @ 4:00 pm – 5:00 pm Zoom: https://stanford.zoom.us/j/93524639045?pwd=NUV1MFE2clBCYVp3K0FJNlJFTGswdz09


Lauren Oakden-Rayner, PhD
Director of Research in Medical Imaging
Royal Adelaide Hospital
Senior Research Fellow
Australian Institute for Machine Learning

Title: Medical AI Safety – A Clinical Perspective

Abstract:
Medical artificial intelligence is rapidly moving into clinics, particularly in imaging-based specialties such as radiology. This transition is producing many new challenges, as the regulatory environment has struggled to keep up and AI training for healthcare workers is virtually non-existent. Dr. Oakden-Rayner will provide a clinical safety perspective on medical AI, discuss a range of identified risks and potential harms, and discuss possible solutions to mitigate these risks as this exciting field continues to develop.

Bio:
Dr. Lauren Oakden-Rayner (FRANZCR, PhD) is the Director of Research in Medical Imaging at the Royal Adelaide Hospital and is a senior research fellow at the Australian Institute for Machine Learning. Her research explores the safe translation of artificial intelligence technologies into clinical practice, both from a technical and clinical perspective.